文献速递颅颌面外科显微修复重建

颅颌面手术中髂骨骨移植供区并发症的系统综述

Donor Site Morbidities of Iliac Crest Bone Graft in Craniofacial Surgery: A Systematic Review.
PubMed 文献 · Ann Plast Surg · 2019-01-01

主要适应证为口腔颌面(50%)和唇裂重建(40%)。术后第1天和第14天即刻疼痛VAS平均分分别为6.3和1.3。慢性并发症发生率低于既往报道,支持髂骨骨移植仍是可行的术式选择。

要点

  • 髂骨骨移植供区慢性并发症发生率低,慢性疼痛3.1%,慢性步态异常1.5%
  • 急性步态异常(45.7%)和急性神经改变(17.8%)较常见,但多为一过性
  • 术后第1天即刻疼痛VAS平均6.3,第14天降至1.3

核心结论

  • 髂骨骨移植供区慢性并发症发生率低于既往文献报道,仍为可行的术式选择。

主要发现

  • 主要手术适应证为口腔颌面(50%)和唇裂重建(40%)。
  • 术后第1天和第14天即刻疼痛VAS平均分分别为6.3和1.3。
  • 供区并发症发生率:急性步态异常45.7%,慢性步态异常1.5%;急性神经改变17.8%,慢性神经改变1.4%;肥厚性/疼痛性瘢痕9.1%;慢性疼痛3.1%;血肿2.2%;血清肿2.0%;感染1.0%;髂嵴骨折1.2%;肌肉疝0%。

关键数值与推荐

  • 各并发症加权发生率:急性步态异常45.7%,慢性步态异常1.5%,急性神经改变17.8%,慢性神经改变1.4%,肥厚性/疼痛性瘢痕9.1%,慢性疼痛3.1%,血肿2.2%,血清肿2.0%,感染1.0%,髂嵴骨折1.2%,肌肉疝0%。
  • 即刻疼痛VAS平均分:术后第1天6.3,第14天1.3。

临床怎么用

  • 可用于颅颌面手术前对髂骨骨移植供区并发症的术前谈话和知情同意。
  • 术后应关注急性步态异常和神经改变,但多数为暂时性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The iliac crest bone graft (ICBG) is criticized for high donor site morbidity. Recent research suggests this morbidity is related to the patient population for which the ICBG is harvested. This systematic review is the first to delineate the type and incidence of ICBG donor site complications in craniofacial surgery. METHODS: Two independent reviewers conducted a systematic review of multiple databases (MEDLINE, EMBASE, CINAHL, PEDRO, and Cochrane Central Register of Controlled Trials) from 1917 to 2017. All studies utilizing the ICBG for craniofacial indications were included. Donor site morbidities, including immediate and chronic pain, hematoma, seroma, infection, hypertrophic/painful scarring, nerve injury, muscle herniation, iliac crest fracture, and gait disturbance, were recorded. A weighted incidence for each morbidity, excluding immediate pain, was calculated. An average visual analog scale score was calculated for immediate pain. RESULTS: Forty-four studies, with 2801 patients, were included. Oral and maxillofacial (50%) and cleft reconstruction (40%) were the primary indications for surgery. Average immediate pain visual analog scale scores on postoperative days 1 and 14 were 6.3 and 1.3, respectively. The incidence of donor site morbidities was as follows: acute (45.7%) and chronic (1.5%) gait disturbance, acute (17.8%) and chronic nerve changes (1.4%), hypertrophic/painful scar (9.1%), chronic pain (3.1%), hematoma (2.2%), seroma (2.0%), infection (1.0%), iliac crest fracture (1.2%), and muscle herniation (0%). CONCLUSIONS: Chronic morbidity was lower than previously documented. Rare chronic morbidity illustrates that the ICBG remains a viable surgical option. The authors hope this review will facilitate surgical planning and informed consent.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Boehm KS, Al-Taha M, Morzycki A, et al. Donor Site Morbidities of Iliac Crest Bone Graft in Craniofacial Surgery: A Systematic Review. Ann Plast Surg. 2019. PMID: 30562201. doi:10.1097/SAP.0000000000001682

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。